Announcement of Exercise of Over-allotment Option

The offering of shares in the form of GDRs was priced on 12 October at US$12 per GDR with one GDR representing an interest in one ordinary share. The over-allotment shares were sold at the offer price.

The total Offering size, including the over-allotment option, is US$289,218,828 comprising 24,101,569 GDRs. Following the exercise of the over-allotment option, MD Medical Group's free float will be approximately 32.1%

For further information please contact:

Learn more about MD Medical Group. Visit the Company’s web site at www.mcclinics.com

Company Highlights

• Operating in the highly attractive Russian private healthcare service market.
• Leading position in high-quality women’s health and paediatrics.
• Growing network of healthcare facilities in attractive regions of Russia.
• Strong emphasis on providing the highest-quality clinical care with a full-cycle service offering at its hospital.
• Highly qualified medical professionals led by renowned clinicians.
• Track record of strong operational and financial performance.

Company Overview

The Company operates nine modern healthcare facilities, including a 250-bed hospital and eight outpatient clinics in Moscow, St. Petersburg, Ufa and Perm. In addition, two franchised outpatient clinics operate in Kyiv and one franchised outpatient clinic in Irkutsk. By the end of 2012, the Company plans to open a state-of-the art 182-bed hospital in the affluent Moscow suburb of Lapino, which will focus on maternity care, paediatrics, trauma and rehabilitation. In 2013, the Company expects to begin construction of a hospital in Ufa.

As of December 30, 2012, the Company employed approximately 1,461 medical specialists and staff. The Company’s shares are listed on the London Stock Exchange (LSE ticker “MDMG”) in the form of Global Depositary Receipts (GDRs) since October 12, 2012.

IMPORTANT NOTICE

This press release is, for UK regulatory purposes, an advertisement and not a prospectus and investors should not subscribe for or purchase any securities referred to in this press release except on the basis of information in the prospectus published by MD Medical Group Investments Plc. This press release does not constitute or form part of any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for, any shares or other securities of MD Medical Group Investments Plc, nor shall any part of it nor the fact of its distribution form part of or be relied on in connection with any contract or investment decision relating thereto, nor does it constitute a recommendation regarding the securities of MD Medical Group Investments Plc.

Some of the information in this press release may contain projections or other forward-looking statements regarding future events. The Company wishes to caution you that these statements are only predictions and that actual events or results may differ materially. The Company does not intend to update these statements to reflect events and circumstances occurring after the date hereof or to reflect the occurrence of unanticipated events.